These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 12834366)

  • 1. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.
    Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A
    Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate control in atrial fibrillation.
    Van Gelder IC; Rienstra M; Crijns HJ; Olshansky B
    Lancet; 2016 Aug; 388(10046):818-28. PubMed ID: 27560277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
    Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
    Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate control in atrial fibrillation: looking beyond the average heart rate.
    Ahmad K; Dorian P
    Curr Opin Cardiol; 2006 Mar; 21(2):88-93. PubMed ID: 16470141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological approaches in the treatment of atrial fibrillation.
    Tamargo J; Caballero R; Delpón E
    Curr Med Chem; 2004 Jan; 11(1):13-28. PubMed ID: 14754423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Atrial Fibrillation.
    Prystowsky EN; Padanilam BJ; Fogel RI
    JAMA; 2015 Jul; 314(3):278-88. PubMed ID: 26197188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of atrial fibrillation in the setting of heart failure.
    Crijns HJ; Van den Berg MP; Van Gelder IC; Van Veldhuisen DJ
    Eur Heart J; 1997 May; 18 Suppl C():C45-9. PubMed ID: 9152675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation: drug therapies for ventricular rate control and restoration of sinus rhythm.
    Chandramouli BV; Kotler MN
    Geriatrics; 1998 Jun; 53(6):46-8, 51-2, 54, 57-60. PubMed ID: 9634106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
    Olshansky B; Rosenfeld LE; Warner AL; Solomon AJ; O'Neill G; Sharma A; Platia E; Feld GK; Akiyama T; Brodsky MA; Greene HL;
    J Am Coll Cardiol; 2004 Apr; 43(7):1201-8. PubMed ID: 15063430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in medication use, 1980-1996.
    Stafford RS; Robson DC; Misra B; Ruskin J; Singer DE
    Arch Intern Med; 1998 Oct; 158(19):2144-8. PubMed ID: 9801182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of the management of atrial fibrillation in patients with heart failure.
    Khand AU; Rankin AC; Kaye GC; Cleland JG
    Eur Heart J; 2000 Apr; 21(8):614-32. PubMed ID: 10731399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.
    Perez A; Touchette DR; DiDomenico RJ; Stamos TD; Walton SM
    Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of atrial fibrillation].
    Fazekas T; Csanádi Z; Varró A
    Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.